18 -19
November

Venture Capital & Private Equity Boston

Investment Challenges and Opportunities in Emerging Biotech Markets

Le Meridien Cambridge Boston

Fully Booked

What to expect

Timely information, interactive format

Real insights are shared in conversations, not lectures. That’s why our unique roundtable format guarantees real learning and ensures you only attend discussions that deliver value to you.

Join as many as four roundtable discussions, each with up to 20 other subject experts, networking with top-level peers in an informal, relaxed and sociable environment.

Meet Our Facilitators

Our panel of facilitators plays a key role in shaping the agenda for the day. Whilst we’re busy connecting with the best industry experts, take a look at our facilitators.

Alex Zisson

Managing Director H.I.G. Capital

David Sherris

CEO Attivare Therapeutics

Session – Next Generation OV and New Combinational Approaches for Treatment of Solid Tumors 
Dr. Sherris has over 30 years’ experience in translational medicine involving basic research, pharmaceutics and diagnostics.  Dr. Sherris has been a successful serial entrepreneur developing biotechnology companies from the ground up, devising corporate strategy, enacting programs and carrying companies through funding and acquisition.  Dr. Sherris prides himself as a “roll up your sleeves” CEO, entrepreneur, business development officer, drug developer and scientist, not simply a delegator. Dr. Sherris has worked with venture capital companies where he has both advised and raised finances for biotech companies.  Dr. Sherris has been employed by pharmaceutical and biotechnology companies to manage external (academic groups and contract research organizations) and internal (directly manage, augment and expand internal scientific programs) research and development. Dr. Sherris has been a frequently invited guest speaker at biopharmaceutical business and scientific conferences, a published author and holder of patents in a wide range of therapeutic areas including oncology, ophthalmology, dermatology, neurology, gene therapy and infectious disease.  Dr. Sherris has held positions of increasing responsibility in public and private companies. Dr. Sherris has developed drugs from the bench to the clinic, partnered technologies to pharmaceutical companies and raised capital for companies at the triple digit million dollar levels.

Christina Ansted

Senior Managing Partner RCP Venture Capital

Giovanni Abbadessa

Chief Medical Officer ModeX Therapeutics

Govinda Bhisetti

Vice President and Head of Computational Chemistry Cellarity

Huseyin Mehmet

Executive Director, New Ventures University of Massachusetts Medical School

Huseyin Mehmet is a drug hunter and research scientist with >35 years’ experience in basic and clinical academic research and in pharmaceutical / biotechnology drug discovery. He received his PhD from the Medical Research Council in the UJ and went on to work at University College London, the Imperial Cancer Research Fund (now Cancer Research UK), Cold Spring Harbor Lab, USA and then took a faculty position at Imperial College School of Medicine. There his work focused on cerebral hypoxic ischemic injury in neonates and he was part of the team that developed mild hypothermia for the treatment of birth asphyxia. In 2006 Huseyin left the UK to join Merck and Co, in the USA. He worked in biomarker discovery, target identification and several drug discovery programs up to clinical candidate selection. For the next few years, he took on roles with increasing responsibility in several biotech companies and also consulted for a number of start-up companies working with prominent VC firms (e.g. Atlas Ventures and Versant Ventures). Since 2021, Huseyin has led the New Ventures team in the BRIDGE Innovation and Business Development office at UMass Chan Medical School, where he is responsible for the scientific partnering of intellectual property arising from faculty discoveries.

Michael Janes

Co Founder – Chief Revenue Officer RCP Venture Capital

Mohamed Kassam

Head, Bioinformatics Zifo

Prateek Katti

Investor Newpath Partners

Robert Gabriel

Board Member, Managing Partner Ashur Capital

Our Agenda

Private Equity, Venture Capital & Strategic Partnerships
Maximizing ROI in Clinical Trials: Navigating Risk, Innovation, and Opportunity

Alex Zisson,
Managing Director,
H.I.G. Capital

Private Equity, Venture Capital & Strategic Partnerships
Balancing Cost-Effectiveness with Data Reliability in Decentralized Models

Private Equity, Venture Capital & Strategic Partnership
Exploring the Key Strategies for Improving the Cost-Efficiency of Clinical Trials and Increasing ROI for Investors?

Robert Gabriel,
Board Member, Managing Partner,
Ashur Capital

Private Equity, Venture Capital & Strategic Partnerships
Evaluating the Role of Strategic Partnerships in Mitigating Risks and Enhancing Funding or Expertise for Clinical Trials

Private Equity, Venture Capital & Strategic Partnerships
De-Risking Investment in Clinical Trials: Strategies for Startups and VCs

Private Equity, Venture Capital & Strategic Partnerships
Topic TBC

Private Equity, Venture Capital & Strategic Partnerships
Early-Stage Science, Late-Stage Discipline: What Today’s Investors Want

Christina Ansted,
Senior Managing Partner,
RCP Venture Capital

Michael Janes,
Co Founder – Chief Revenue Officer,
RCP Venture Capital

Private Equity, Venture Capital & Strategic Partnerships
What Are the Emerging Trends in Venture Capital for Drug Discovery and Biotech Startups?

Private Equity, Venture Capital & Strategic Partnerships
Strategic Alliances and Investment Strategies: Fueling the Future of Drug Discovery

Prateek Katti,
Investor,
Newpath Partners

Private Equity, Venture Capital & Strategic Partnerships
Partnering for Progress: How Big Pharma & Biotech Forge the Next Wave of Innovation

Private Equity, Venture Capital & Strategic Partnerships
Topic TBC

David Sherris,
President and CEO,
Attivare Therapeutics

Further Information

Interested in attending this virtual roundtable or running your own? Drop us a message today and we will get in touch

Here To Help

Need help registering your team? Just get in touch and a member of the team will be happy to help.

Europe

USA East

USA West

Webinars

Europe

R&D

Investment Dinners & Spotlights

Venture Capital & Private Equity

Venture Capital & Private Equity Boston

<img class="lazy" decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%2012%2016'%3E%3C/svg%3E" data-src="https://proventainternational.com/wp-content/uploads/2020/12/location.png" >Le Meridien Cambridge Boston

Timely information, interactive format

Meet Our Facilitators

Alex Zisson

David Sherris

Christina Ansted

Giovanni Abbadessa

Govinda Bhisetti

Huseyin Mehmet

Michael Janes

Mohamed Kassam

Prateek Katti

Robert Gabriel

Our Agenda

Day 1 : 18th of Nov, 2025

Registration And Welcome

Opening Keynote Presentation Giovanni Abbadessa, Chief Medical Officer, ModeX Therapeutics

Roundtable Roundtable Tracks

Refreshment Break

Networking / 1-1 Meetings

Roundtable Roundtable Tracks

Roundtable Roundtable Tracks

Networking Lunch

Networking / 1-1 Meetings

Networking / 1-1 Meetings

Afternoon Keynote Presentation

Roundtable Roundtable Tracks

Afternoon Refreshment Break

PANEL DISCUSSION

Drinks & Canapes Reception

Day 2 : 19th of November, 2025

Registration And Welcome

Opening Keynote Presentation Govinda Bhisetti, Vice President and Head, Computational Chemistry, Cellarity

Roundtable

Refreshment Break

Networking / 1-1 Meetings

Roundtable Roundtable Tracks

Roundtable Roundtable Tracks

Networking Lunch

Networking / 1-1 Meetings

Networking / 1-1 Meetings

Afternoon Keynote Presentation

Roundtable Roundtable Tracks

Afternoon Refreshment Break

PANEL DISCUSSION

Drinks & Canapes Reception

Further Information

Here To Help

Select days you wish to attend You can add multiple days

VAT Excluded

Select days you wish to attend You can add multiple days

Pass includes:

VAT Excluded

About You

Your Address

About Your Company

This is required field*

Bone/Osteoporosis

Immunology

Orthopaedics

Cardiovascular

Infectious diseases

Pulmonology

CNS

Inflammation

Psychiatry

Dermatology

Internal diseases

Respiratory

Diabetes

Metabolic diseases

Le Meridien Cambridge Boston